Fig. 3
From: APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC
Forest plot illustrating the effects of APE1 percentile grouping on the prognosis of abundance of CD4+ T cells for RFS. Patients were divided into different groups according to every increment of 25% percentile of APE1 expression level. When APE1 level was less than 25%, the abundance of CD4+ T cells was a favorable prognostic factor (P < 0.001), however, with the increase of APE1 level, the impact of CD4 + T cells on prognosis was gradually weakened (P > 0.05)